Skip to main content
EJNMMI Research
Fig. 4 | EJNMMI Research

Fig. 4

From: Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy

Fig. 4

Dose–response relationships between a normalised white blood cell (WBC), b normalised neutrophil granulocyte, c normalised platelet and d absolute haemoglobin (Hb) concentrations and accumulated absorbed dose (from all given treatments combined). All shown blood data were sampled 31–45 days after administration of 177-Lu-DOTATATE. Markers are transparent so that overlapping points are resolved as darker markers. The linear fits are shown as lines along with the corresponding confidence intervals of the fits (shaded area)

Back to article page